These observations indicate a possible involvement of CPEB2 in early events of gliomagenesis. In addition, the mutation rate of CPEB2 in glioma patients are very low in cBioPortal database (Supplementary Fig. 1). Here, CPEB2 is linked to central nervous system cancer.